{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:03:12Z","timestamp":1794092592320,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disease-modifying treatments for Alzheimer\u2019s disease highlight the need for early detection of cognitive decline. However, at present, most primary care providers do not perform routine cognitive testing, in part due to a lack of access to practical cognitive assessments, as well as time and resources to administer and interpret the tests. Brief and sensitive digital cognitive assessments, such as the Digital Clock and Recall (DCR\u2122), have the potential to address this need. Here, we examine the advantages of DCR over the Mini-Mental State Examination (MMSE) in detecting mild cognitive impairment (MCI) and mild dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We studied 706 participants from the multisite Bio-Hermes study (age mean\u2009\u00b1\u2009SD\u2009=\u200971.5\u2009\u00b1\u20096.7; 58.9% female; years of education mean\u2009\u00b1\u2009SD\u2009=\u200915.4\u2009\u00b1\u20092.7; primary language English), classified as cognitively unimpaired (CU;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009360), mild cognitive impairment (MCI;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009234), or probable mild\u00a0Alzheimer\u2019s dementia (pAD;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009111) based on a review of medical history with selected cognitive and imaging tests. We evaluated cognitive classifications (MCI and early dementia) based on the DCR and the MMSE against cohorts based on the results of the Rey Auditory Verbal Learning Test (RAVLT), the Trail Making Test-Part B (TMT-B), and the Functional Activities Questionnaire (FAQ). We also compared the influence of demographic variables such as race (White vs. Non-White), ethnicity (Hispanic vs. Non-Hispanic), and level of education (\u2265\u200915\u00a0years vs.\u2009&lt;\u200915\u00a0years) on the DCR and MMSE scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The DCR was superior on average to the MMSE in classifying mild cognitive impairment and early dementia, AUC\u2009=\u20090.70 for the DCR vs. 0.63 for the MMSE. DCR administration was also significantly faster (completed in less than 3\u00a0min regardless of cognitive status and age). Among 104 individuals who were labeled as \u201ccognitively unimpaired\u201d by the MMSE (score\u2009\u2265\u200928) but actually had verbal memory impairment as confirmed by the RAVLT, the DCR identified 84 (80.7%) as impaired. Moreover, the DCR score was significantly less biased by ethnicity than\u00a0the\u00a0MMSE, with no significant difference in the\u00a0DCR score between Hispanic and non-Hispanic individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DCR outperforms the MMSE in detecting and classifying cognitive impairment\u2014in a fraction of the time\u2014while being not influenced by a patient\u2019s ethnicity. The results support the utility of DCR as a sensitive and efficient\u00a0cognitive assessment in primary care settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov identifier NCT04733989.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-023-01367-7","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T05:02:58Z","timestamp":1704171778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia"],"prefix":"10.1186","volume":"16","author":[{"given":"Ali","family":"Jannati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Toro-Serey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Gomes-Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Ciesla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Tobyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Pascual-Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"1367_CR1","unstructured":"World Health Organization. WHO Disability and Health Fact Sheet. Cited 2023 Apr 10. Available from: https:\/\/apps.who.int\/iris\/rest\/bitstreams\/1343030\/retrieve."},{"issue":"2","key":"1367_CR2","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"key":"1367_CR3","volume-title":"Alzheimer\u2019s Disease Facts and Figures, 17","author":"J Gaugler","year":"2021","unstructured":"Gaugler J, Bryan James TJ, Reimer J, Weuve J. Alzheimer\u2019s Disease Facts and Figures, 17. Alzheimer\u2019s Dementia: Chicago, IL; 2021."},{"key":"1367_CR4","unstructured":"Eisai Inc. A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer\u2019s Disease. clinicaltrials.gov; 2022 . Cited 2023 May 16. Report No.: NCT03887455. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03887455."},{"key":"1367_CR5","unstructured":"A Study of Donanemab (LY3002813) in Participants With Early Alzheimer\u2019s Disease (TRAILBLAZER-ALZ 2) - Full Text View - ClinicalTrials.gov. Cited 2023 May 17. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04437511."},{"key":"1367_CR6","doi-asserted-by":"publisher","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023. Cited 2023 Jul 22. https:\/\/doi.org\/10.1001\/jama.2023.13239.","DOI":"10.1001\/jama.2023.13239"},{"key":"1367_CR7","unstructured":"Food and Drug Administration (FDA). Aducanumab (marketed as Aduhelm) Information. Cited 2021 Sep 5. Available from: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/aducanumab-marketed-aduhelm-information."},{"key":"1367_CR8","unstructured":"Food and Drug Administration (FDA). LEQEMBITM (lecanemab-irmb) [package insert]. Cited 2023 Jan 12. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761269s000lbl.pdf."},{"issue":"1","key":"1367_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"1367_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","volume":"9","author":"M Kivipelto","year":"2013","unstructured":"Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, et al. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013;9(6):657\u201365.","journal-title":"Alzheimers Dement"},{"issue":"10248","key":"1367_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346.","journal-title":"Lancet"},{"key":"1367_CR12","first-page":"83","volume":"3","author":"SE O\u2019Bryant","year":"2016","unstructured":"O\u2019Bryant SE, Edwards M, Johnson L, Hall J, Villarreal AE, Britton GB, et al. A blood screening test for Alzheimer\u2019s disease. Alzheimer\u2019s Dement Diagn Assess Dis Monit. 2016;3:83\u201390.","journal-title":"Alzheimer\u2019s Dement Diagn Assess Dis Monit"},{"key":"1367_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","volume":"14","author":"SE Counts","year":"2017","unstructured":"Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ. Biomarkers for the early detection and progression of Alzheimer\u2019s disease. Neurotherapeutics. 2017;14:35\u201353.","journal-title":"Neurotherapeutics"},{"key":"1367_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fnagi.2019.00332","volume":"11","author":"X Dong","year":"2019","unstructured":"Dong X, Nao J, Shi J, Zheng D. Predictive value of routine peripheral blood biomarkers in Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:332.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"1367_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","volume":"78","author":"N Mattsson","year":"2012","unstructured":"Mattsson N, Rosen E, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology. 2012;78(7):468\u201376.","journal-title":"Neurology"},{"issue":"1","key":"1367_CR16","first-page":"248","volume":"11","author":"C Gillis","year":"2019","unstructured":"Gillis C, Mirzaei F, Potashman M, Ikram MA, Maserejian N. The incidence of mild cognitive impairment: a systematic review and data synthesis. Alzheimers Dement Diagn Assess Dis Monit. 2019;11(1):248\u201356.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"12","key":"1367_CR17","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaneurol.2022.3543","volume":"79","author":"JJ Manly","year":"2022","unstructured":"Manly JJ, Jones RN, Langa KM, Ryan LH, Levine DA, McCammon R, et al. Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: the 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project. JAMA Neurol. 2022;79(12):1242.","journal-title":"JAMA Neurol"},{"issue":"4","key":"1367_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"1367_CR19","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1002\/alz.13051","volume":"19","author":"S Mattke","year":"2023","unstructured":"Mattke S, Batie D, Chodosh J, Felten K, Flaherty E, Fowler NR, et al. Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care. Alzheimer\u2019s & Dementia. 2023;19(9):4252\u20139.","journal-title":"Alzheimer\u2019s & Dementia."},{"key":"1367_CR20","doi-asserted-by":"crossref","unstructured":"Souillard-Mandar W, Penney D, Schaible B, Pascual-Leone A, Au R, Davis R. DCTclock: Clinically Interpretable and Automated Artificial Intelligence Analysis of Drawing Behavior for Capturing Cognition. Frontiers in Digital Health. 2021;3. Cited 2022 Feb 1. Available from: https:\/\/www.ncbi.nlm.nih.gov\/labs\/pmc\/articles\/PMC8553980\/.","DOI":"10.3389\/fdgth.2021.750661"},{"issue":"14","key":"1367_CR21","doi-asserted-by":"publisher","first-page":"e1844","DOI":"10.1212\/WNL.0000000000011697","volume":"96","author":"DM Rentz","year":"2021","unstructured":"Rentz DM, Papp KV, Mayblyum DV, Sanchez JS, Klein H, Souillard-Mandar W, et al. Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults. Neurology. 2021;96(14):e1844.","journal-title":"Neurology"},{"key":"1367_CR22","doi-asserted-by":"crossref","unstructured":"Kaplan E. The process approach to neuropsychological assessment of psychiatric patients. J Neuropsychiatr Clin Neurosci. 1990;2(1):72\u201387.","DOI":"10.1176\/jnp.2.1.72"},{"key":"1367_CR23","first-page":"42","volume":"3","author":"WP Milberg","year":"2009","unstructured":"Milberg WP, Hebben N, Kaplan E, Grant I, Adams K. The Boston process approach to neuropsychological assessment. Neuropsychol Assess Neuropsychiatr Neuromed Disord. 2009;3:42\u201365.","journal-title":"Neuropsychol Assess Neuropsychiatr Neuromed Disord"},{"issue":"8","key":"1367_CR24","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1080\/13854046.2013.833295","volume":"27","author":"DJ Libon","year":"2013","unstructured":"Libon DJ, Swenson R, Ashendorf L, Bauer RM, Bowers D. Edith Kaplan and the Boston process approach. Clin Neuropsychol. 2013;27(8):1223\u201333.","journal-title":"Clin Neuropsychol"},{"key":"1367_CR25","doi-asserted-by":"crossref","unstructured":"Libon DJ, Swenson R, Lamar M, Price CC, Baliga G, Pascual-Leone A, et al. The Boston process approach and digital neuropsychological assessment: past research and future directions. J Alzheimers Dis. 2022:1\u201314. Preprint(Preprint).","DOI":"10.3233\/JAD-220096"},{"key":"1367_CR26","unstructured":"Beauregard D. Bio-Hermes\/Apheleia: Leveraging biomarker trials to phenotype participants for interventional trials, reducing participant\/site burden, screen fail rates and overall costs. Oral Presentation presented at; 2023 Mar 2; AD\/PD Conference 2023. Gothenburg, Sweden"},{"key":"1367_CR27","unstructured":"Global Alzheimer\u2019s Platform. Bio-Hermes study. Cited 2022 May 11. Available from: https:\/\/globalalzplatform.org\/biohermesstudy\/."},{"issue":"11","key":"1367_CR28","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/gps.2036","volume":"23","author":"DT Leube","year":"2008","unstructured":"Leube DT, Weis S, Freymann K, Erb M, Jessen F, Heun R, et al. Neural correlates of verbal episodic memory in patients with MCI and Alzheimer\u2019s disease\u2013\u2013a VBM study. Int J Geriatr Psychiatr. 2008;23(11):1114\u20138.","journal-title":"Int J Geriatr Psychiatr"},{"issue":"2","key":"1367_CR29","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.neuroimage.2010.09.005","volume":"54","author":"DA Wolk","year":"2011","unstructured":"Wolk DA, Dickerson BC. Alzheimer\u2019s Disease Neuroimaging Initiative. Fractionating verbal episodic memory in Alzheimer\u2019s disease. Neuroimage. 2011;54(2):1530\u20139.","journal-title":"Neuroimage."},{"issue":"6","key":"1367_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.conb.2011.10.021","volume":"21","author":"M Gallagher","year":"2011","unstructured":"Gallagher M, Koh MT. Episodic memory on the path to Alzheimer\u2019s disease. Curr Opin Neurobiol. 2011;21(6):929\u201334.","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"1367_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000336224","volume":"2","author":"D Silva","year":"2012","unstructured":"Silva D, Guerreiro M, Maroco J, Santana I, Rodrigues A, Bravo Marques J, et al. Comparison of four verbal memory tests for the diagnosis and predictive value of mild cognitive impairment. Dement Geriatr Cogn Disord Extra. 2012;2(1):120\u201331.","journal-title":"Dement Geriatr Cogn Disord Extra"},{"issue":"4","key":"1367_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11065-017-9361-5","volume":"27","author":"S Belleville","year":"2017","unstructured":"Consortium for the Early Identification of Alzheimer\u2019s disease-Quebec, Belleville S, Fouquet C, Hudon C, Zomahoun HTV, Croteau J. Neuropsychological measures that predict progression from mild cognitive impairment to Alzheimer\u2019s type dementia in older adults: a systematic review and meta-analysis. Neuropsychol Rev. 2017;27(4):328\u201353.","journal-title":"Neuropsychol Rev."},{"issue":"3","key":"1367_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10994-015-5529-5","volume":"102","author":"W Souillard-Mandar","year":"2016","unstructured":"Souillard-Mandar W, Davis R, Rudin C, Au R, Libon DJ, Swenson R, et al. Learning classification models of cognitive conditions from subtle behaviors in the digital clock drawing test. Mach Learn. 2016;102(3):393\u2013441.","journal-title":"Mach Learn"},{"issue":"1","key":"1367_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JAD-191089","volume":"75","author":"C Dion","year":"2020","unstructured":"Dion C, Arias F, Amini S, Davis R, Penney D, Libon DJ, et al. cognitive correlates of digital clock drawing metrics in older adults with and without mild cognitive impairment. J Alzheimers Dis. 2020;75(1):73\u201383.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1367_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1017\/S1355617722000091","volume":"29","author":"EF Matusz","year":"2023","unstructured":"Matusz EF, Price CC, Lamar M, Swenson R, Au R, Emrani S, et al. Dissociating statistically determined normal cognitive abilities and mild cognitive impairment subtypes with DCTclock. J Int Neuropsychol Soc. 2023;29(2):148\u201358.","journal-title":"J Int Neuropsychol Soc."},{"key":"1367_CR36","volume-title":"Handbook of normative data for neuropsychological assessment","author":"M Mitrushina","year":"2005","unstructured":"Mitrushina M, Boone KB, Razani J, D\u2019Elia LF. Handbook of normative data for neuropsychological assessment. New York: Oxford University Press; 2005."},{"issue":"2","key":"1367_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","volume":"19","author":"T Tombaugh","year":"2004","unstructured":"Tombaugh T. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203\u201314.","journal-title":"Arch Clin Neuropsychol"},{"issue":"3","key":"1367_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323\u20139.","journal-title":"J Gerontol"},{"issue":"4","key":"1367_CR39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1177\/1073191121991215","volume":"29","author":"DA Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez DA, Gonzales MM, Resch ZJ, Sullivan AC, Soble JR. Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity. Assessment. 2022;29(4):748\u201363.","journal-title":"Assessment"},{"issue":"438","key":"1367_CR40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/01621459.1997.10474007","volume":"92","author":"B Efron","year":"1997","unstructured":"Efron B, Tibshirani R. Improvements on Cross-Validation: The 632+ Bootstrap Method. J Am Stat Assoc. 1997;92(438):548\u201360. https:\/\/doi.org\/10.1080\/01621459.1997.10474007.","journal-title":"J Am Stat Assoc."},{"key":"1367_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00415-009-5387-9","volume":"257","author":"A Bour","year":"2010","unstructured":"Bour A, Rasquin S, Boreas A, Limburg M, Verhey F. How predictive is the MMSE for cognitive performance after stroke? J Neurol. 2010;257:630\u20137.","journal-title":"J Neurol"},{"key":"1367_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-015-0103-3","volume":"15","author":"PT Trzepacz","year":"2015","unstructured":"Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ, Alzheimer\u2019s Disease Neuroimaging Initiative. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC geriatrics. 2015;15:1\u20139.","journal-title":"BMC geriatrics."},{"issue":"5","key":"1367_CR43","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.12740\/PP\/45368","volume":"50","author":"N Ciesielska","year":"2016","unstructured":"Ciesielska N, Soko\u0142owski R, Mazur E, Podhorecka M, Polak-Szabela A, K\u0119dziora-Kornatowska K. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta Analysis Psychiatr Pol. 2016;50(5):1039\u201352.","journal-title":"Meta Analysis Psychiatr Pol"},{"key":"1367_CR44","unstructured":"R: The R Project for Statistical Computing. Cited 2023 May 19. Available from: https:\/\/www.r-project.org\/."},{"issue":"43","key":"1367_CR45","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LD, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"key":"1367_CR46","unstructured":"Taiyun. taiyun\/corrplot. 2023. Cited 2023 May 19. Available from: https:\/\/github.com\/taiyun\/corrplot."},{"key":"1367_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw. 2015;67:1\u201348.","journal-title":"J Stat Softw"},{"key":"1367_CR48","unstructured":"Iannone R, Cheng J, Schloerke B, Hughes E, Lauer A, Seo J, et al. gt: Easily Create Presentation-Ready Display Tables. 2023. Cited 2023 May 19. Available from: https:\/\/cran.r-project.org\/web\/packages\/gt\/index.html."},{"issue":"3","key":"1367_CR49","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M. Classification and Regression by randomForest. R News. 2002;2(3):18\u201322.","journal-title":"R News"},{"key":"1367_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"1367_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M. Building Predictive Models in R Using the caret Package. J Stat Softw. 2008;28(5):1\u201326.","journal-title":"J Stat Softw"},{"key":"1367_CR52","doi-asserted-by":"publisher","first-page":"960648","DOI":"10.3389\/fpsyt.2022.960648","volume":"13","author":"M Casagrande","year":"2022","unstructured":"Casagrande M, Marselli G, Agostini F, Forte G, Favieri F, Guarino A. The complex burden of determining prevalence rates of mild cognitive impairment: a systematic review. Front Psychiatry. 2022;13:960648. https:\/\/doi.org\/10.3389\/fpsyt.2022.960648.","journal-title":"Front Psychiatry"},{"issue":"5","key":"1367_CR53","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jalz.2012.10.001","volume":"9","author":"DR Roalf","year":"2013","unstructured":"Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for the classification of Alzheimer\u2019s disease, mild cognitive impairment and healthy aging. Alzheimers Dement. 2013;9(5):529\u201337.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"1367_CR54","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/gps.5136","volume":"34","author":"MZAA Ghafar","year":"2019","unstructured":"Ghafar MZAA, Miptah HN, O\u2019Caoimh R. Cognitive screening instruments to identify vascular cognitive impairment: a systematic review. Int J Geriatr Psychiatry. 2019;34(8):1114\u201327.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"21","key":"1367_CR55","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009;73(21):1738\u201345.","journal-title":"Neurology"},{"issue":"3","key":"1367_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/S1041610201007694","volume":"13","author":"RN Jones","year":"2001","unstructured":"Jones RN, Gallo JJ. Education Bias in the Mini-Mental State Examination. Int Psychogeriatr. 2001;13(3):299\u2013310.","journal-title":"Int Psychogeriatr"},{"key":"1367_CR57","doi-asserted-by":"crossref","unstructured":"Cognitive Functioning and Impairment Among Rural Elderly Hispanics and Non-Hispanic Whites as Assessed by the Mini-Mental State Examination | The Journals of Gerontology: Series B | Oxford Academic. Cited 2023 Jul 28. Available from: https:\/\/academic.oup.com\/psychsocgerontology\/article\/54B\/4\/P223\/693054.","DOI":"10.1093\/geronb\/54B.4.P223"},{"issue":"12","key":"1367_CR58","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/0895-4356(94)90082-5","volume":"47","author":"M Bohnstedt","year":"1994","unstructured":"Bohnstedt M, Fox PJ, Kohatsu ND. Correlates of mini-mental status examination scores among elderly demented patients: the influence of race-ethnicity. J Clin Epidemiol. 1994;47(12):1381\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"1367_CR59","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1532-5415.2005.53269.x","volume":"53","author":"S Borson","year":"2005","unstructured":"Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Simplifying Detection of Cognitive Impairment: Comparison of the Mini-Cog and Mini-Mental State Examination in a Multiethnic Sample. J Am Geriatr Soc. 2005;53(5):871\u20134.","journal-title":"J Am Geriatr Soc"},{"key":"1367_CR60","doi-asserted-by":"publisher","unstructured":"Ethnic Differences in Mini-Mental State Examination (MMSE) Scores: Where You Live Makes a Difference - Espino - 2001 - Journal of the American Geriatrics Society - Wiley Online Library. Cited 2023 Jul 28. Available from: https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/abs\/. https:\/\/doi.org\/10.1046\/j.1532-5415.2001.49111.x.","DOI":"10.1046\/j.1532-5415.2001.49111.x"},{"key":"1367_CR61","unstructured":"Use of the Mini-Mental State Examination (MMSE) in a Communi...\u00a0: The Journal of Nervous and Mental Disease. Cited 2023 Jul 28. Available from: https:\/\/journals.lww.com\/jonmd\/Abstract\/1986\/10000\/Use_of_the_Mini_Mental_State_Examination__MMSE__in.5.aspx7."},{"issue":"2","key":"1367_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ageing\/19.2.91","volume":"19","author":"C Brayne","year":"1990","unstructured":"Brayne C, Calloway P. The Association of Education and Socioeconomic Status with the Mini Mental State Examination and the Clinical Diagnosis of Dementia in Elderly People. Age Ageing. 1990;19(2):91\u20136.","journal-title":"Age Ageing"},{"issue":"1","key":"1367_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","volume":"15","author":"KA Matthews","year":"2019","unstructured":"Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D, et al. Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged \u226565 years. Alzheimers Dement. 2019;15(1):17\u201324.","journal-title":"Alzheimers Dement"},{"key":"1367_CR64","unstructured":"Alzheimer\u2019s Drug Discovery Foundation website. Cited 2023 Aug 10. GAP Innovations, PBC. Available from: https:\/\/www.alzdiscovery.org\/research-and-grants\/portfolio-details\/21461570."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01367-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T05:11:46Z","timestamp":1704172306000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01367-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1367"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01367-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was explained to participants verbally and through written informed consent that was approved by the local IRB of each site participating in the GAP consortium (see the Bio-Hermes study website [\n                      \n                      ] for a list of study sites). If, in the opinion of the site principal investigator, the participant did not have the capacity to sign the informed consent form, a legally authorized representative was used to grant consent on behalf of the participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"APL is a co-founder and Chief Medical Officer of Linus Health and a co-founder of TI Solutions and declares ownership of shares or share options in the company. APL serves as a paid member of the scientific advisory boards for Neuroelectrics, Magstim Inc., TetraNeuron, Skin2Neuron, MedRhythms, and Hearts Radiant. DB is a co-founder and Chief Executive Officer of Linus Health and declares ownership of shares or share options in the company. JS is Chief Product Officer of Linus Health and declares ownership of shares or share options in the company. All other authors are employees of Linus Health and declare ownership of shares or share options in the company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}